{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:49:19Z","timestamp":1786650559051,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/2229-5178.115538","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T14:16:48Z","timestamp":1374675408000},"page":"246","source":"Crossref","is-referenced-by-count":20,"title":["Ingenol mebutate: A novel topical drug for actinic keratosis"],"prefix":"10.4103","volume":"4","author":[{"given":"Suruchi","family":"Aditya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.115538-1","first-page":"3","volume-title":"Nonmelanoma skin cancer","author":"Samarasinghe","year":"2012","journal-title":"J Cutan Aesthet Surg","ISSN":"https:\/\/id.crossref.org\/issn\/0974-2077","issn-type":"print"},{"key":"key-10.4103\/2229-5178.115538-2","first-page":"373","volume-title":"Non melanoma skin cancer in India: Current scenario","author":"Panda","year":"2010","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/2229-5178.115538-3","first-page":"46","volume-title":"Malignant transformation of actinic keratoses to squamous cell carcinoma in an albino","author":"Ramalingam","year":"2009","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/2229-5178.115538-4","first-page":"121","volume-title":"Ingenol mebutate (ingenol 3- angelate; Pep 005): Focus on its uses in the treatment of non melanoma skin cancer","author":"Lebwohl","year":"2012","journal-title":"Expert Rev Dermatol"},{"key":"key-10.4103\/2229-5178.115538-5","first-page":"20","volume-title":"Non surgical innovations in the treatment of non melanoma skin cancer","author":"Amini","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"key-10.4103\/2229-5178.115538-6","first-page":"20","volume-title":"An update on nonmelanoma skin cancer","author":"Patel","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"key-10.4103\/2229-5178.115538-7","first-page":"1","volume-title":"Ingenol mebutate:an introduction","author":"Fallen","year":"2012","journal-title":"Skin Therapy Lett"},{"key":"key-10.4103\/2229-5178.115538-8","first-page":"486","volume-title":"Dual mechanism of action of Ingenol mebutate gel for topical treatement of acinic keratosis: rapid lesion necrosis followed by lesion - specific immune response","author":"Rosen","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2229-5178.115538-9","first-page":"174","volume-title":"The protein kinase C agonist PEP 005 (ingenol 3- angelate) in the treatment of human cancer: A balance between efficacy and toxicity","author":"Ersvaer","year":"2010","journal-title":"Toxins (Basel)"},{"key":"key-10.4103\/2229-5178.115538-10","first-page":"16","volume-title":"PEP 005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double- blind, vehicle- controlled, multicentre, phase IIa study","author":"Siller","year":"2009","journal-title":"Australas J Dermatol"},{"key":"key-10.4103\/2229-5178.115538-11","doi-asserted-by":"crossref","unstructured":"Anderson L, Schmieder GJ, Werschler WP, Tschen EH, Ling MR, Stough DB, et al. Randomized, double- blind, double- dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis. J Am Acad Dermatol 2009;60:934-43.","DOI":"10.1016\/j.jaad.2009.01.008"},{"key":"key-10.4103\/2229-5178.115538-12","first-page":"1010","volume-title":"Ingenol mebutate gel for actinic keratosis","author":"Lebwohl","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2229-5178.115538-13","first-page":"3053","volume-title":"Immunostimulatory cancer chemotherapy using local ingenol 3- angelate and synergy with immunotherapies","author":"Le","year":"2009","journal-title":"Vaccine"},{"key":"key-10.4103\/2229-5178.115538-14","first-page":"99","volume-title":"PEP 005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: Results of a randomized phase IIa trial","author":"Siller","year":"2010","journal-title":"Australas J Dermatol"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:20:18Z","timestamp":1786648818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2229-5178.115538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"alternative-id":["115538"],"URL":"https:\/\/doi.org\/10.4103\/2229-5178.115538","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}